AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2002 OCT 2 - (NewsRx.com & NewsRx.net) -- Developing countries stand to profit most from advances in genome science, write Samuel Broder, Stephen Hoffman and Peter Hotez in the September 2002 issue of EMBO Reports.
They claim that biotechnology coupled with genomics might emerge as the key technology in the 21st century for improving global health and probably even avoiding major political conflicts and wars.
The authors warned that we must no longer view the diseases of the developing world in purely medical or public health contexts. Infectious diseases could pose a major risk to the economic survival of many developing nations. Even more striking, recent data have suggested that some of these diseases may have wider implications for geopolitical stability or the probability that a nation will experience armed conflict.
"If it is possible to transfer weapon technology to the developing world it should be possible to transfer innovative countertechnologies to these countries. We believe that genomics could be such a countertechnology," said Broder.
The progress resulting from genomic research is significant. It has already advanced the knowledge of infectious diseases. The complete genomic sequences of many pathogens responsible for morbidity and mortality in the developing world are now established. The new ...
Source: HighBeam Research, Political stability of developing countries rests on physical...